Abstract 6843: A joint model for integrating serial methylation-based tumor fraction and ESR1 assessment to forecast overall survival in patients with ER+/HER2- metastatic breast cancer.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Institutions: Guardant (United States), Princess Margaret Cancer Centre
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7148764108
Cites:
Cited by:
Related to:
